Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cisplatin Adverse Reaction”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Large-scale testing (Phase 3)UnknownNCT02250872
What this trial is testing

Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury

Who this might be right for
CancerCisplatin Adverse Reaction
Seoul National University Bundang Hospital 182
Early research (Phase 1)Study completedNCT00003144
What this trial is testing

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health 44
Not applicableStudy completedNCT02890030
What this trial is testing

The Platinum Study Comparison Group

Who this might be right for
Testicular Neoplasms
Lawrence Einhorn 102
Testing effectiveness (Phase 2)Study completedNCT01139281
What this trial is testing

The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans

Who this might be right for
OtotoxicityHearing Loss
University of Brasilia 15
Large-scale testing (Phase 3)Study completedNCT00652132
What this trial is testing

Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer

Who this might be right for
Liver CancerOtotoxicity
University of Birmingham 116
Very early researchTemporarily pausedNCT05756660
What this trial is testing

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

Who this might be right for
Ototoxicity, Drug-Induced
Children's Hospital Medical Center, Cincinnati 33
Testing effectiveness (Phase 2)UnknownNCT04817904
What this trial is testing

Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity

Who this might be right for
Cisplatin Adverse Reaction
Cairo University 65
Not applicableEnded earlyNCT00213642
What this trial is testing

Tc-99m Renography and Cisplatin-induced Nephrotoxicity

Who this might be right for
CancerDrug ToxicityKidney Failure
University Hospital, Rouen 20
Not applicableLooking for participantsNCT06551857
What this trial is testing

The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life

Who this might be right for
CancerHearing Loss OtotoxicCognitive Decline+1 more
Turku University Hospital 250
Large-scale testing (Phase 3)Study completedNCT00477607
What this trial is testing

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

Who this might be right for
OtotoxicityUnspecified Adult Solid Tumor
US Department of Veterans Affairs 39
Testing effectiveness (Phase 2)UnknownNCT00004264
What this trial is testing

Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
University of Wisconsin, Madison
Not applicableUnknownNCT01285674
What this trial is testing

Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.

Who this might be right for
CisplatinOtotoxicityIntratympanic Steroids
Ziv Hospital 20
Testing effectiveness (Phase 2)UnknownNCT06297369
What this trial is testing

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Who this might be right for
Cisplatin Adverse ReactionCisplatin NephrotoxicityCisplatin Induced Peripheral Neuropathy+2 more
Ain Shams University 60
Post-approval studies (Phase 4)Ended earlyNCT04226456
What this trial is testing

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Who this might be right for
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicity+1 more
Centre Hospitalier Universitaire Saint Pierre 19
Testing effectiveness (Phase 2)Study completedNCT00077311
What this trial is testing

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
AnemiaDrug/Agent Toxicity by Tissue/OrganLung Cancer+1 more
Alliance for Clinical Trials in Oncology 160
Testing effectiveness (Phase 2)UnknownNCT04351308
What this trial is testing

Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma

Who this might be right for
OsteosarcomaSurvivalChemotherapy Effect+1 more
Peking University People's Hospital 60
Not applicableWithdrawnNCT02382068
What this trial is testing

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Who this might be right for
Malignant NeoplasmOtotoxicity
Aaron Moberly
Post-approval studies (Phase 4)UnknownNCT03069820
What this trial is testing

Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury

Who this might be right for
Liver Injury, Drug-Induced
Second Affiliated Hospital of Nanchang University 120
Not applicableUnknownNCT05247671
What this trial is testing

Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity

Who this might be right for
Cisplatin Adverse Reaction
Ain Shams University 89
Not applicableUnknownNCT00578760
What this trial is testing

Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?

Who this might be right for
Hearing LossOtotoxicity
University Health Network, Toronto 110
Next Page